Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants

Pediatrics

Volumn 110, Issue 3, 2002, Pages 534-539

  Van Wassenaer, Aleid G ^a   Briët, Judy M ^a   Van Baar, Anneloes ^a   Smit, Bert J ^a   Tamminga, Pieter ^a   De Vijlder, Jan J M ^b   Kok, Joke H ^a  

^a Departments of Neonatology   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Follow up studies; Hypothyroidism; Thyroxine; Very low birth weight infant

Indexed keywords

THYROXINE;

ARTICLE; BRAIN DEVELOPMENT; CALCULATION; CHILD DEVELOPMENT; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; FREE THYROXINE INDEX; HUMAN; MAJOR CLINICAL STUDY; MENTAL DEVELOPMENT; MOTOR DEVELOPMENT; NEUROLOGIC DISEASE; NEWBORN; PERINATAL DEVELOPMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; NEUROLOGIC EXAMINATION; PSYCHOMOTOR PERFORMANCE; THYROXINE;

EID: 0036725377     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.110.3.534     Document Type: Article

References (37)

1. Thyroid hormones and brain development
2. Is neurophysiological development related to maternal hypothyroidism or to maternal hypothyroxinemia?
3. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy
4. Materno-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis
5. Timing of vulnerability of the brain into iodine deficiency in endemic cretinism
6. Outcome of severe congenital hypothyroidism: Closing the developmental gap with early high dose leveothyroxine treatment
7. Thyroid function in the preterm infant: A longitudinal assessment
8. Low thyroxinaemia occurs in the majority of very preterm newborns
9. Thyroid function in very preterm infants: Influences of gestational age and disease
10. Transient hypothyroxinemia associated with developmental delay in very preterm infants
11. The relation between neonatal thyroxine levels and the neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants
12. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age
13. Low plasma triiodothyronine concentrations and outcome in preterm infants
14. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up
15. Thyroxine-binding proteins
16. Serum concentrations of thyrotropin, thyroid hormones and thyroid hormone binding proteins during acute and recovery stages of idiopathic respiratory distress syndrome
17. Developmental follow-up of very low birthweight premature infants with low free thyroxine
18. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation
19. Neonatal thyroxine supplementation in very preterm children: Developmental outcome evaluated at early school age
20. Thyroid function in preterm newborns; is T4 treatment required in infants <27 weeks' gestational age?
21. Thyroid function in very preterm infants, possible implications
22. Is free thyroxine accurately measurable at room temperature?
23. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the national institute of child health and human development neonatal research network, 1993-1994
24. Hypothyroxinemia in premature infants: Is thyroxine treatment necessary?
25. Neurobehavioral deficits in premature graduates of intensive care - Potential medical and environmental risk factors
26. Motor and cognitive development in children with congenital hypothyroidism: A long-term evaluation of the effects of neonatal treatment
27. Neonatal thyroxine supplementation in very preterm infants: Developmental outcome at early school age
28. 5′-Monodeiodinase activity in the developing human cerebral cortex
29. Reference ranges for newer thyroid function tests in premature infants
30. Results of a double-blind study on thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia
31. L-Thyroxine treatment of preterm newborns: Clinical and endocrine effects
32. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats